DhritiT's blog
The global neurothrombectomy devices market size stood at
USD 493.4 million in 2020. The market is estimated to rise from USD 562.2
million in 2021 to USD 1,090.7 million by 2028 at a 9.9% CAGR during the
forecast period. Fortune Business
Insights™ has deep-dived into these insights in its latest research report
titled, “Neurothrombectomy Devices Market, 2021-2028.”
According to the study, surging cases of ischemic strokes
across advanced and emerging economies are expected to lead to innovation in
neurothrombectomy devices. For instance, 87% of all strokes reported in the
U.S. are ischemic strokes, according to the CDC. Besides, soaring demand for
minimally invasive procedures will further the penetration of advanced devices.
To gain more insights into the market with a detailed table
of content and figures, Click Here:
https://www.fortunebusinessinsights.com/enquiry/sample/neurothrombectomy-devices-market-106513
COVID-19 Impact
Reduction in
Neurothrombectomy Procedures to Challenge Stakeholders
The COVID-19 pandemic had a notable influence on the
healthcare sector, with quarantine and travel restrictions pronounced in 2020
and 2021. Notably, a dip in non-essential surgeries further challenged leading
companies vying to expand their neurothrombectomy portfolio. According to the
International Journal of Stroke, the total mechanical thrombectomy procedures
decreased to 12.7% from March to May in 2020 globally. Prevailing trends
indicate governments could boost investments in the healthcare industry, redefining
the global landscape.
Major Players
Profiled in the Market Report:
• Stryker
(U.S.)
• Medtronic
(Ireland)
• Penumbra,
Inc. (U.S.)
• Boston
Scientific Corporation (U.S.)
• Phenox
GmbH (Germany)
• MicroVention
Inc. (U.S.)
To get information on various segments, share your queries
with us
We are the best market research reports provider in the
industry. Report Ocean believes in providing quality reports to clients to meet
the top line and bottom line goals
which will boost your market share in today’s competitive
environment. Report Ocean is a ‘one-stop solution’ for individuals,
organizations,
and industries that are looking for innovative market
research reports.
·
Table of Contents
·
Introduction
o
Research Scope
o
Market Segmentation
o
Research Methodology
o
Definitions and Assumptions
·
Executive Summary
·
Market Dynamics
o
Market Drivers
o
Market Restraints
o
Market Opportunities
·
Key Insights
o
Incidence of Strokes, in
Key Region/Countries, 2020
o
New Device Type
Launches, By Key Players
o
Key Industry
Developments – Mergers, Acquisitions, Partnership and etc.
o
Impact of COVID-19 on
Global Neurothrombectomy Devices Market
To gain more insights into the market with a
detailed table of content and figures, Click Here:
About Us:
Fortune Business Insights™ offers expert corporate analysis
and accurate data, helping organizations of all sizes make timely decisions. We
tailor innovative solutions for our clients, assisting them to address
challenges distinct to their businesses. Our goal is to empower our clients
with holistic market intelligence, giving a granular overview of the market
they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
U.S. Dialysis Services Market: Dialysis Clinic, Inc. Introduces Open House Unit to Spread Awareness Regarding Home Dialysis: Fortune Business Insights
The U.S. dialysis services market size was USD 25.87 billion in 2020. The market is expected to grow from USD 26.20 billion in 2021 to USD 32.46 billion in 2028 at a CAGR of 3.11% in the 2021-2028 period.
To get more information on the regional analysis of this market, Request a Free sample: https://www.fortunebusinessinsights.com/enquiry/sample/u-s-dialysis-services-market-105704
List of Key Players Covered in the Report
- Fresenius Medical Care AG & Co. (Bad Homburg, Germany)
- DaVita Inc. (Denver, Colorado, United States)
- American Renal® Associates (Beverly, Massachusetts, United States)
- S. Renal Care, Inc.( Plano, Texas, United States)
- Satellite Healthcare (San Jose, United States)
- Baxter (Illinois, United States)
- Braun Melsungen AG, (Melsungen, Germany)
- Becton, Dickinson and Company (New Jersey, United States)
- DCI Inc. (Tennessee, United States)
- NxStage Medical, Inc. (Massachusetts, United States)
To get information on various segments,
https://www.fortunebusinessinsights.com/enquiry/customization/u-s-dialysis-services-market-105704
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years.
The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study.
TOC:
- Introduction
- Market Scope
- Market Segmentation
- Market Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
TOC continuous https://www.fortunebusinessinsights.com/toc/u-s-dialysis-services-market-105704
share your queries with us https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-dialysis-services-market-105704
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Pune, India, 21st
February 2022: The U.S. diagnostic imaging services market
size was USD 94.31 billion in 2020. The market is expected to grow from USD 104.65 billion in 2021
to USD 176.50 billion in 2028, exhibiting a CAGR of 7.8% during the forecast
period. High safety and efficiency of the product and growing geriatric
population may foster market development. Fortune Business Insights™ provides this information in its report titled “U.S. Diagnostic Imaging Services
Market, 2021-2028”.
U.S.
diagnostic imaging services is a medical procedure that provides highly
efficient and safe diagnostics. It includes CT scans, MRI scans, nuclear
medicines scans, ultrasound, and x-rays. The safety and the efficiency of
diagnostic tools may boost the services’ adoption. Furthermore, the rising geriatric
population may attract consumers towards effective diagnostic procedures,
thereby increasing demand for the services. In addition, increasing insurance
coverage and the launch of new diagnostic imaging services may bolster the U.S.
diagnostic imaging services market share.
Please visit:
https://www.fortunebusinessinsights.com/u-s-diagnostic-imaging-services-market-106552
Segmentation
By
procedures, the market is segmented into CT, MRI, X-ray, ultrasound, and
others. Based on application, it is classified into cardiology, neurology,
oncology, orthopedics, gynecology, and others. As per payor, it is clubbed into
public health insurance and private health insurance/out of pocket. On the
basis of setting, it is categorized into imaging centers, hospitals, and
others.
List of Key Players Profiled in the
U.S. Diagnostic Imaging Services Market Report
·
RadNet,
Inc. (Los Angeles, U.S.)
·
Akumin,
Inc. (Plantation, U.S.)
·
Rayus
Radiology (St Louis Park, U.S.)
·
MedQuest
(Alpharetta, U.S.)
·
LucidHealth,
Inc. (Columbus, U.S.)
·
US
Radiology Specialists (Raleigh, U.S.)
·
Radiology
Partners (El Segundo, U.S.)
·
Envision
Radiology (Colorado Springs, U.S.)
·
Capitol
Imaging Services (Metairie, U.S.)
To get information on various segments, share your queries
with us
The objective of the study is to define market sizes of
different segments & countries in recent years and to forecast the values
to the coming eight years.
The report is designed to incorporate both qualitative and
quantitative aspects of the industry within each of the regions and countries
involved in the study.
Furthermore, the
report also caters the detailed information about the crucial aspects such as
driving factors & challenges which will define the future growth of the
market.
Additionally, the
report shall also incorporate available opportunities in micro markets for
stakeholders to invest along with the detailed analysis of
competitive landscape and Application offerings of key
players.
About Us:
Fortune Business Insights™
delivers accurate data and innovative corporate analysis, helping organizations
of all sizes make appropriate decisions. We tailor novel solutions for our
clients, assisting them to address various challenges distinct to their
businesses. Our aim is to empower them with holistic market intelligence,
providing a granular overview of the market they are operating in.
Phone:
U.S. :+1 424 253 0390
U.K. : +44 2071 939123
APAC : +91 744 740 1245
Market Overview:
Pune, India, 19th July 2022: The global epinephrine market size was valued at USD 1.60 billion in 2021. The market is projected to grow from USD 1.75 billion in 2022 to USD 3.63 billion by 2029, exhibiting a CAGR of 11.0% during the forecast period.
This information is provided by Fortune Business Insights, in its report titled, “Epinephrine Market, 2022-2029.”
To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:
Segments:
Auto-injectors Segment to Observe Sturdy Growth during the Forecast Period
On the basis of product type, the market is segmented into auto-injectors, pre filled syringes and ampoules & vials.
The auto-injectors segment led the market by revenue share owing to the advantages of these auto-injectors over other products.
Growing Prevalence of Anaphylaxis Attributable for Domination of the Segment
On the basis of application, the market is segmented into anaphylaxis, cardiac arrest, respiratory disorders, and others.
The anaphylaxis segment led the market during 2021 due to the bolstering incidences of anaphylaxis globally.
Key Industry Development:
March 2022: USWM, LLC. and Adamis Pharmaceuticals Corporation declared the launch and availability of ZIMHI, a high-dose naloxone injection product that is utilized for the treatment of opioid overdose as crisis remedy.
List of Key Players Mentioned in the Report:
- Teva Pharmaceutical Industries Ltd. (Israel)
- Viatris Inc. (U.S.)
- kaleo, Inc. (U.S.)
- Bausch Health Companies Inc. (Canada)
- Amneal Pharmaceuticals LLC. (U.S.)
- USWM, LLC. (U.S.)
- BIOPROJET (France)
- ALK-Abelló A/S (Denmark)
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune Business Insights Pvt. Ltd.
9th Floor, Icon Tower, Baner - Mahalunge Road,
Baner, Pune-411045,
Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
You can also contact us/follow us on:
https://www.facebook.com/FortuneBusinessInsightsPvtLtd
The global veterinary consumables market sizewas USD 1.63
billion in 2020. The market is projected to grow from USD 1.71 billion
in 2021 to USD 2.83 billion by 2028 at a CAGR of 7.4% in the
2021-2028 period.This
information is provided by Fortune
Business Insights in its report titled, “Veterinary Consumables Market, 2021-2028.”
According to our
researchers, the growing consciousness concerning animal fitness and welfare
has resulted in surging demand for veterinary consumables.
Request a Sample: https://www.fortunebusinessinsights.com/enquiry/sample/veterinary-consumables-market-106343
COVID-19
Impact:
Deterioration
in Hospital Tourism to Vet Clinics during Pandemic to Obstruct Growth
The COVID-19 outbreak in 2020
had an adverse influence on the veterinary consumables market. Numerous nations
raised lockdown constraints as well as stay-at-home guidelines by the end of
2020. Nevertheless, the latest outbreak of the novel variant of COVID-19 in the
U.K. and India and uncertainty during 2021 is anticipated to further have an unfavorable
sway on vet performers. Though at present, vet care suppliers in numerous nations
are handling the situation in a more wide-ranging manner as compared to 2020.
Segments:
Based on product, the global market is
classified into anesthesia supplies, ventilator supplies, monitoring supplies,
imaging supplies, and others. Based on animal type, it is segregated into
companion animals and livestock animals. By type, it is branched into
disposable and reusable. On the basis of end-user, it is categorized into
veterinary hospitals, veterinary clinics, and others. Region-wise, it is
studied across North America, Europe, Asia Pacific, and the rest of the
world.
To get to know more about the
short-term and long-term impact of COVID-19 on this market, please visit:https://www.fortunebusinessinsights.com/veterinary-consumables-market-106343
List
of Key Players Mentioned in the Report:
·
Avante Animal Health(Louisville, U.S.)
·
Midmark Corporation (Dayton, U.S.)
·
Smiths Medical (Minneapolis, U.S.)
·
Shenzhen Mindray Bio-Medical Electronics Co.,
Ltd. (Shenzhen, China)
·
B. Braun
Melsungen AG (Melsungen, Germany)
·
VETLAND
MEDICAL SALES & SERVICES (Louisville, U.S.)
·
SunTech
Medical, Inc. (Morrisville, U.S.)
Table
Of Content:
1.
Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2.
Executive Summary
3.
Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
Table Of Content
Continious https://www.fortunebusinessinsights.com/toc/veterinary-consumables-market-106343
About Us:
Fortune Business Insights™ offers expert corporate analysis
and accurate data, helping organizations of all sizes make timely decisions. We
tailor innovative solutions for our clients, assisting them to address
challenges distinct to their businesses. Our goal is to empower our clients
with holistic market intelligence, giving a granular overview of the market
they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights in a new report, titled, “Pneumonia
Testing Market Size, Share & Industry Analysis, Pneumonia Testing
Market By End-user (Hospitals & Clinics, Diagnostic Centers, and Others),
and Regional Forecast, By Type (Streptococcus-based, Legionella-based,
Chlamydophila-based, Viral Pneumonia-based, Mycoplasma Pneumonia-based, and
Others) By Product Type (Instruments and Reagents & Consumables)2023-2029.
Pneumonia Testing Market will exhibit a CAGR of 6.0% between
2023 and 2029, and reach USD 912.5 million by 2029, and the Market value as per
2021 was USD 557.1 million.
To gain more insights into the market with a detailed table
of content and figures, Click Here: https://www.fortunebusinessinsights.com/pneumonia-testing-market-106787
The objective of the study is to define market sizes of
different segments & countries in recent years and to forecast the values
to the coming eight years.
The report is designed to incorporate both qualitative and
quantitative aspects of the industry within each of the regions and countries
involved in the study.
Furthermore, the
report also caters the detailed information about the crucial aspects such as driving
factors & challenges which will define the future growth of the market.
Additionally, the
report shall also incorporate available opportunities in micro markets for
stakeholders to invest along with the detailed analysis of
competitive landscape and Application offerings of key
players.
LIST OF KEY COMPANIES PROFILED:
Quidel Corporation (U.S.)
Abbott (U.S.)
bioMérieux SA (France)
Thermo Fisher Scientific Inc. (U.S.)
INTEC (China)
OpGen (U.S.)
Meridian Bioscience, Inc. (U.S.)
BD (Becton, Dickinson, and Company) (U.S.)
Luminex Corporation (DiaSorin S.p.A.) (U.S.)
To get more information on the regional analysis of this
market visit https://www.fortunebusinessinsights.com/enquiry/sample/pneumonia-testing-market-106787
KEY INDUSTRY PLAYERS:
- NOVIGENIX SA(Switzerland)
- EIKEN CHEMICAL CO., LTD. (Japan)
- Clinical Genomics Technologies Pty Ltd. (U.S.)
- Exact
Sciences Corporation (U.S.)
- Epigenomics
AG (Germany)
- bioMérieux, Inc. (France)
- Olympus Corporation (Japan)
- KARL STORZ SE & Co. KG (Germany)
- FUJIFILM Holdings America Corporation (Japan)
To get more information on the regional analysis of this
market, Request a Free sample: https://www.fortunebusinessinsights.com/enquiry/sample/colorectal-cancer-screening-market-101144
Colorectal Cancer Screening Market
Colorectal
Cancer Screening Market Size, Share & COVID-19 Impact Analysis, By
End-user (Hospitals & Clinics, Clinical Laboratories, Diagnostics Imaging
Centers, and Others),a Fecal Occult Blood Test (FOBT), and Stool-DNA Test),
Colonoscopy, and Others), By Type (Stool-based Tests (Fecal Immunochemical Test
(FIT) and Forecast, 2022-2029.
Fortune Business Insights completed a qualitative study titled
“Colorectal Cancer Screening Market” with 100+ market data tables, pie charts,
graphs, and figures spread across Pages and an easy-to-grasp full analysis. The
most up-to-date technology was used in conjunction with expert industry
knowledge and practical, effective, and innovative solutions to develop this report.
Market penetration-increasing tactics such as new product releases,
geographical expansion, agreements, joint ventures, partnerships, and
acquisitions are discussed. This study of the Colorectal Cancer Screening
Market focuses on numerous submarkets that are anticipated to grow rapidly in
terms of revenue throughout the study’s approximate forecast time frame. The
report’s research, analysis, and insights give you a clear picture of the
market from which to make informed business decisions.
The global colorectal cancer screening market size was
valued at USD 14.32 billion in 2021. The market is projected to grow from USD
17.02 billion in 2022 to USD 22.88 billion by 2029, exhibiting a CAGR of 4.3%
during the forecast period. The global COVID-19 pandemic has been unprecedented
and staggering, with colorectal cancer screening experiencing
lower-than-anticipated demand across all regions compared to pre-pandemic
levels. Based on our analysis, the market exhibited a decline of -59.6% in 2020
as compared to 2019.
To get more information on the regional analysis of this
market, Request a Free sample: https://www.fortunebusinessinsights.com/enquiry/sample/colorectal-cancer-screening-market-101144
Colorectal Cancer (CRC) occurs when the
cancerous cells begin to grow and spread in the colon or rectum part of the
digestive tract. It is also called bowel cancer. Early colorectal cancer cases
begin with the development of non-cancerous polyps and can have no symptoms but
can be detected through screening tests. CRC screening is the detection of the
disease for people who are asymptomatic but at high risk of getting the disease
and are of age 45 and above. Symptoms of CRC depend upon the size and site of
cancer. Major disease symptoms include changes in bowel habits, stool
consistency, blood in the stool, and abdominal discomfort. The increasing
incidence of CRC has increased the need for screening for early diagnosis and
treatment of the disease.
The global colorectal cancer screening
market growth is attributed to its increasing prevalence of disease and rising
government programs in order to control its side effects. Furthermore, the
increasing focus of the market players on the launch of new and advanced
products is one of the major factors driving the market growth.
- For instance, In May 2022, Guardant Health announced the
launch of Shield, a blood-based test for the detection of early-stage
colorectal cancer (CRC), which is available for adults aged 45 and older.
The test requires patients to complete a blood draw and is intended for
adults age 45 and older who are not up to date with recommended screening
guidelines, show no symptoms, and are at average risk for CRC.
KEY INDUSTRY PLAYERS:
- NOVIGENIX SA(Switzerland)
- EIKEN CHEMICAL CO., LTD. (Japan)
- Clinical Genomics Technologies Pty Ltd. (U.S.)
- Exact
Sciences Corporation (U.S.)
- Epigenomics
AG (Germany)
- bioMérieux, Inc. (France)
- Olympus Corporation (Japan)
- KARL STORZ SE & Co. KG (Germany)
- FUJIFILM Holdings America Corporation (Japan)
To get information on various segments,
https://www.fortunebusinessinsights.com/enquiry/sample/colorectal-cancer-screening-market-101144
Reasons
for buying this report:
It offers an analysis of changing
competitive scenario.
For making informed decisions in the
businesses, it offers analytical data with strategic planning methodologies.
Researchers throw light on the dynamics of
the market such as drivers, restraints, trends, and opportunities.
It offers regional analysis of Telehealth
Market along with business profiles of several stakeholders.
It offers seven-year assessment of
Telehealth Market.
It helps in understanding the major key
product segments.
It offers massive data about trending
factors that will influence the progress of the Telehealth Market.
Table
of content
·
Introduction
o
Research Scope
o
Market Segmentation
o
Research Methodology
o
Definitions and Assumptions
·
Executive Summary
·
Market Dynamics
o
Market Drivers
o
Market Restraints
o
Market Opportunities
o
Market Trends
Table of content continuous
To get information on various segments, https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/colorectal-cancer-screening-market-101144
The North American colorectal cancer screening market
generated a revenue of USD 9.27 billion in 2021. The highly aware and
economically stable population is a key factor for the large share of the
market in North America. Moreover, the adoption of technologically advanced and
high-cost tests such as Cologuard, colonoscopies, and other stool-based tests
in the region is also expected to propel the market growth during the forecast
period.
The market in Europe is expected to grow at a significant
CAGR during the forecast period. Increasing demand for screening procedures
such as stool-based testing in European countries, the presence of government
programs, and rising awareness about the disease in key European countries are
some of the major factors expected to boost market growth in Europe.
For instance, United European Gastroenterology (UEG), with
the European Code against Cancer, regulates CRC screening across Europe with
organized, population-based screening programs and proactively promotes
screening.
The market across Asia Pacific region is expected to expand
at a substantial CAGR in the projected years. The enhancement and improvement
of healthcare facilities in Asian countries, increasing CRC incidence the
countries across the region, and the increasing consciousness of the
individuals in terms of better treatment outcomes are driving the regional
market growth.
For instance, as per a research article published by NCBI,
in 2018, in China, in terms of the highest incidence and mortality rate, CRC
ranked fourth and fifth of all cancer cases.
The market in Middle East & Africa, and Latin America
are also expected to expand at a significant CAGR during the forecast period.
The increasing burden of colorectal cancer, rising government initiatives to
create awareness about the disease along with easy availability of screening
tests such as FIT and FOBT are responsible for the growth of the market for
colorectal cancer screening across these regions.
About Us:
Fortune Business Insights™ offers expert corporate analysis
and accurate data, helping organizations of all sizes make timely decisions. We
tailor innovative solutions for our clients, assisting them to address challenges
distinct to their businesses. Our goal is to empower our clients with holistic
market intelligence, giving a granular overview of the market they are
operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
